Has Mary Krebs received payments from drug or device companies?

Yes. Drug and device makers reported $3,523 in general payments to Mary Krebs across 80 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mary Krebs did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mary Krebs come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mary Krebs

Family Medicine · Lebanon, OHNPI 1801912308

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.6% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,581 and has fallen 61.0% since, to $616 in 2025.

$3,523in general payments, 2019–2025

Across 80 payments — averaging $44.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$784
Johnson & Johnson$361
Amgen$357
AbbVie$335
Teva Pharmaceuticals USA, Inc.$246
Novo Nordisk$206
plus $1K from 16 others

What the payments were for

Food & beverage$3,510100%
Education$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	21	$784
Johnson & Johnson	4	$361
Amgen	3	$357
AbbVie(2 entities)	5	$335
Teva Pharmaceuticals USA, Inc.	2	$246
Novo Nordisk	16	$206
Boehringer Ingelheim	6	$185
Lilly USA, LLC	4	$162
Tactile Systems Technology Inc	1	$149
Sanofi Pasteur Inc.	1	$125
Biohaven Pharmaceuticals, Inc.	1	$119
Mallinckrodt Enterprises LLC	1	$100
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$90
Medtronic	1	$63
Merck	4	$56
E.r. Squibb & Sons, L.L.C.	1	$51
Astellas Pharma US Inc	2	$35
Takeda Pharmaceuticals U.S.A., Inc.	2	$35
Amarin Pharma, Inc.	1	$23
GSK	1	$15
Sunovion Pharmaceuticals Inc.	1	$15
Pfizer	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,523 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio →

Other family medicine in Lebanon

Kwabena OtengSpringdale$2M
Brian BeesleyColumbus$1.4M
Darshana PatelBeachwood$648K
Thomas GraceFindlay$503K
Susan RatayAshtabula$379K
Shannon TrotterSpringfield$348K
Michael HeileCincinnati$272K
Bradley EverlyMaumee$266K
Tricia BedrickCuyahoga Falls$259K
David NeidhardtLima$248K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →